Lilly is counting on next-generation incretin medicines like Retatrutideas well as its oral GLP-1 Orforglipronto eventually pick up the torch from its current diabetes and obesity mainstays Mounjaro and Zepbound, both of which are underpinned by Lillys dual GIP/GLP-1 receptor agonist Tirzepatide
The murky online marketplace for compounded semaglutide has kept global regulatory agencies busy
What we know today will likely expand significantly in the coming years
As a physician-led medical spa, we provide safe, medically supervised weight loss treatments tailored to your needs
GLP-1 Drugs Affect Your Gut and Brain These medications also enhance insulin secretion, which can result in better blood sugar control in addition to weight loss, says Sara Velayati, MD, an obesity medicine specialist at Montefiore Einsteins Fleischer Institute Medical Weight Center in New York
Cardiometabolic Safety: Assessing cardiovascular and renal outcomes in animal models to inform human safety profiles
